Target intelligence / Profile preview

Pelvic floor musculature

Molecular classification
Other
01

Overview

The **pelvic floor musculature** refers collectively to the group of skeletal muscles and associated connective tissue forming the base of the pelvic cavity in both men and women[1][2][3][4][5][7]. The primary components are the **levator ani** muscles—subdivided into pubococcygeus, puborectalis, and iliococcygeus—and the **coccygeus (ischiococcygeus) muscle**[1][4][5]. These muscles support the pelvic organs (bladder, uterus/prostate, and rectum), maintain urinary and fecal continence, facilitate childbirth, and contribute to sexual function[1][2][3][5][7]. They are innervated mainly by branches of the pudendal nerve (S2–S4) and other sacral nerves[1][4][5]. Dysfunction or weakening of this musculature can result in disorders such as pelvic organ prolapse, various forms of incontinence, and sexual disorders[3][4][7]. The pelvic floor is not a single molecular or receptor-based therapeutic target, but rather an anatomical and functional muscle group, which is why it is not generally regarded as a traditional "therapeutic target" in molecular medicine. **Note:** - This entry is marked as *is_incorrect: true* because "pelvic floor musculature" is an anatomical muscle group rather than a molecular target, receptor, enzyme, transporter, or other entity typically considered a direct therapeutic target in pharmacology or molecular medicine. No drugs directly target the pelvic floor musculature at the molecular level, although interventions such as physical therapy or, in some cases, neuromodulation may affect its function[4][7]. - No canonical abbreviation or molecular aliases exist, and the "molecular classification" is best described as "Other" (anatomical, not molecular). - Drugs do not interact with the pelvic floor musculature as a unique molecular entity, so mechanisms specific to a receptor or enzyme do not apply. - No specific biomarkers or direct safety concerns (in clinical drug development sense) are identified beyond general issues related to muscle injury or dysfunction.

Other names
Pelvic floorPelvic floor musclesPelvic diaphragm
02

Biological functions

Support of pelvic organsMaintenance of urinary and fecal continenceAssistance in childbirthSexual functionCore stabilization
03

Disease associations

Pelvic organ prolapseIncontinence (urinary and fecal)Pelvic floor dysfunctionSexual dysfunctionOther
04

Safety considerations

Trauma or injury during childbirth can weaken musclesSurgery or aging can affect functionOverexertion or inappropriate exercise may exacerbate dysfunction

Beyond the preview

Go deeper on Pelvic floor musculature.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelvic floor musculature.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call